DXB Share Price Performance
AU$0.36
-0.04 (-10.00%)
Price AU$0.36
Share Pricen/a
Dimerix Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
DXB Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Dimerix Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.027
- 100.00%
- -219.94%
- 0%
About DXB
- Founded
- n/a
- Employees
- 15
- CEO
- WebsiteView website
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is headquartered in Fitzroy, Australia.
